CAMK2A and neuroblastoma: To assess the effect of CaMK2A upregulation in vivo, quantitative immunoblotting was performed using a human-derived neuroblastoma SH-SY5Y cell line because it has been used to study the relations of epigenetic biomarkers with academic performance and neuronal disorders associated with neurocognitive disorders [36, 46–50].